1. Academic Validation
  2. A new inhibitor of apoptosis from vaccinia virus and eukaryotes

A new inhibitor of apoptosis from vaccinia virus and eukaryotes

  • PLoS Pathog. 2007 Feb;3(2):e17. doi: 10.1371/journal.ppat.0030017.
Caroline Gubser 1 Daniele Bergamaschi Michael Hollinshead Xin Lu Frank J M van Kuppeveld Geoffrey L Smith
Affiliations

Affiliation

  • 1 Department of Virology, Faculty of Medicine, Imperial College London, London, United Kingdom. c.gubser@imperial.ac.uk
Abstract

A new Apoptosis inhibitor is described from vaccinia virus, camelpox virus, and eukaryotic cells. The inhibitor is a hydrophobic, multiple transmembrane protein that is resident in the Golgi and is named GAAP (Golgi anti-apoptotic protein). Stable expression of both viral GAAP (v-GAAP) and human GAAP (h-GAAP), which is expressed in all human tissues tested, inhibited Apoptosis induced by intrinsic and extrinsic apoptotic stimuli. Conversely, knockout of h-GAAP by siRNA induced cell death by Apoptosis. v-GAAP and h-GAAP display overlapping functions as shown by the ability of v-GAAP to complement for the loss of h-GAAP. Lastly, deletion of the v-GAAP gene from vaccinia virus did not affect virus replication in Cell Culture, but affected virus virulence in a murine Infection model. This study identifies a new regulator of cell death that is highly conserved in evolution from Plants to insects, amphibians, mammals, and poxviruses.

Figures